Hemoglobin-based blood substitutes are being developed as oxygen-carrying agents for the prevention of ischemic tissue damage and hypovolemic (low blood volume) shock.

Orforglipron is a small-molecule, nonpeptide glucagon-like peptide-1 (GLP-1) receptor agonist in clinical development for type 2 diabetes and weight management. Additional data on the efficacy and ...

Early diagnosis of type 2 diabetes can help prevent complications. Learn about the tests doctors use to diagnose the condition.

Blood cell disorders impair the formation and function of red blood cells, white blood cells, or platelets. Learn more.

Iron-refractory iron deficiency anemia (IRIDA) is a genetic form of anemia. Learn about the causes, symptoms, diagnosis, and treatment of this condition.

Hemoglobin and hematocrit both measure red blood cells in the body. Learn what levels are low or high and what it means for your health.

WEDNESDAY, June 25, 2025 (HealthDay News) -- The oral small-molecule glucagon-like peptide-1 receptor agonist, orforglipron, reduced glycated hemoglobin (HbA1c) over 40 weeks in adults with early type ...